Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions

Copyright © 2022 Elsevier Inc. All rights reserved..

OBJECTIVE: To investigate specific imaging and patient-related factors associated with a false negative (FN) MRI-targeted prostate fusion biopsies (TBx) of suspicious MRI lesions.

METHODS: Retrospective study of men with PI-RADS 4 or 5 lesions November, 2015-December 2020 with TBx and systematic biopsy (SBx) performed. Only FN and true positive (TP) targeted lesions were included. FN biopsy was defined as a negative TBx with a positive systematic core in the ROI or perilesional sextant. Logistic regression was used to determine the association of patient and imaging-specific factors with the probability of a FN TBx.

RESULTS: 361 PI-RADS 4 or 5 lesions in 304 patients, including 67 FN (19%) and 294 TP (81%) were included. There was a significant inverse association between lesion size (OR: 0.94, P-value: .02), presence of a suspicious DRE (OR: 0.36, P-value: .02) and PSA density (OR: 0.01, P-value: .004) on the probability of obtaining a FN TBx. There was no association between age, biopsy indication, use of an enema before MRI, prostate size, or discrepant US and MRI segmentation volumes on the probability of a FN TBx.

CONCLUSION: In this cohort, SBx detected 19% of csPCa missed on TBx. Smaller PI-RADS 4/5 lesions, lower PSAD values, and a normal DRE were all associated with an increased probability of a FN TBx.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:167

Enthalten in:

Urology - 167(2022) vom: 30. Sept., Seite 165-170

Sprache:

Englisch

Beteiligte Personen:

Movassaghi, Miyad [VerfasserIn]
Ahmed, Firas [VerfasserIn]
Patel, Hanisha [VerfasserIn]
Luk, Lyndon [VerfasserIn]
Hyams, Elias [VerfasserIn]
Wenske, Sven [VerfasserIn]
Shaish, Hiram [VerfasserIn]

Links:

Volltext

Themen:

EC 3.4.21.77
Journal Article
Prostate-Specific Antigen

Anmerkungen:

Date Completed 28.09.2022

Date Revised 06.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.urology.2022.04.026

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM340621303